BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19365601)

  • 1. Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat: possible role in amelioration of insulin resistance and hepatic steatosis.
    Yokozawa J; Sasaki T; Ohwada K; Sasaki Y; Ito JI; Saito T; Kawata S
    J Gastroenterol; 2009; 44(6):583-91. PubMed ID: 19365601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
    Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats.
    Ran J; Hirano T; Adachi M
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E227-32. PubMed ID: 15082419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pioglitazone on stearoyl-CoA desaturase in obese Zucker fa/fa rats.
    Toyama T; Kudo N; Hibino Y; Mitsumoto A; Nishikawa M; Kawashima Y
    J Pharmacol Sci; 2007 Jun; 104(2):137-45. PubMed ID: 17538229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue stearoyl-CoA desaturase 1 index is increased and linoleic acid is decreased in obesity-prone rats fed a high-fat diet.
    Cedernaes J; Alsiö J; Västermark A; Risérus U; Schiöth HB
    Lipids Health Dis; 2013 Jan; 12():2. PubMed ID: 23298201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of palmitoyl-CoA chain elongation by clofibric acid in the liver of Zucker fa/fa rats.
    Toyama T; Kudo N; Mitsumoto A; Kawashima Y
    Lipids; 2005 May; 40(5):463-70. PubMed ID: 16094855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
    Yamamoto E; Dong YF; Kataoka K; Yamashita T; Tokutomi Y; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2008 Sep; 52(3):573-80. PubMed ID: 18678790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of renin-angiotensin system blockade on the liver steatosis in rats on long-term high-fat diet].
    Chen YH; Yuan L; Chen YY; Qi CJ
    Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):197-201. PubMed ID: 18785501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats.
    Okada K; Hirano T; Ran J; Adachi M
    Hypertens Res; 2004 Apr; 27(4):293-9. PubMed ID: 15127887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats.
    Tovar AR; Torre-Villalvazo I; Ochoa M; Elías AL; Ortíz V; Aguilar-Salinas CA; Torres N
    J Lipid Res; 2005 Sep; 46(9):1823-32. PubMed ID: 15995177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opuntia ficus indica (nopal) attenuates hepatic steatosis and oxidative stress in obese Zucker (fa/fa) rats.
    Morán-Ramos S; Avila-Nava A; Tovar AR; Pedraza-Chaverri J; López-Romero P; Torres N
    J Nutr; 2012 Nov; 142(11):1956-63. PubMed ID: 23014486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet.
    Yang ZH; Miyahara H; Takeo J; Hatanaka A; Katayama M
    Lipids Health Dis; 2011 Oct; 10():189. PubMed ID: 22027268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats.
    Muñoz MC; Argentino DP; Dominici FP; Turyn D; Toblli JE
    J Hypertens; 2006 Aug; 24(8):1607-17. PubMed ID: 16877964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary walnut oil modulates liver steatosis in the obese Zucker rat.
    Fink A; Rüfer CE; Le Grandois J; Roth A; Aoude-Werner D; Marchioni E; Bub A; Barth SW
    Eur J Nutr; 2014; 53(2):645-60. PubMed ID: 23942585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of stearoyl-CoA desaturase 1 increases liver MUFA content in obese Zucker but not Goto-Kakizaki rats.
    Karahashi M; Ishii F; Yamazaki T; Imai K; Mitsumoto A; Kawashima Y; Kudo N
    Lipids; 2013 May; 48(5):457-67. PubMed ID: 23539346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of leptin, troglitazone, and dietary fat on stearoyl CoA desaturase.
    Kakuma T; Lee Y; Unger RH
    Biochem Biophys Res Commun; 2002 Oct; 297(5):1259-63. PubMed ID: 12372423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats.
    Godoy-Lugo JA; Thorwald MA; Hui DY; Nishiyama A; Nakano D; Soñanez-Organis JG; Ortiz RM
    Endocrine; 2022 Jan; 75(1):92-107. PubMed ID: 34327606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.